Plaintiffs attorneys suing over the breast cancer drug Taxotere want a federal judge to sanction defendant Sanofi-Aventis U.S. LLC for filing a motion filled with “unfounded accusations” that are “indecent and vexatious” in an attempt to get information on outside funding for the litigation, according to the National Law Journal. The pushback comes amid a […]
Filed Under: Taxotere News – Lawsuits, Settlements, Information
Class action lawsuits are frequently filed against pharmaceutical companies for serious complications and harm caused by prescription medications. This article lists the top class action drug lawsuits pending in courts throughout the United States in 2017.
A list of the 22 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 1991 to 2013, ordered by the size of the total settlement.
Trying to find the best lawyer for a Taxotere lawsuit can be a difficult and time-consuming task. As you search for an attorney to hire after you or a loved one has suffered injuries, it’s important to ask potential candidates the following questions: Do you specialize in medical malpractice? How many years of experience do you […]
As of this time, there has been no group or individual settlement. However, our law firm is investigating potential cases for patients and their families against the drug manufacturer for side effects caused by Taxotere. A recent lawsuit has been filed against the chemotherapy drug manufacturer Sanofi-Aventis, alleging the company failed to warn patients and doctors about […]
A lawsuit was recently filed against Taxotere manufacturer Sanofi-Aventis, alleging the company failed to warn patients and doctors about the increased risks of permanent hair loss. If this side effect had been disclosed, physicians would’ve prescribed different chemotherapy drugs that did not produce this adverse effect, the lawsuit alleges. In fact, if the risks been known about Taxotere, […]
Taxotere (docetaxel) is a chemotherapy drug approved in the treatment of breast cancer, non-small cell lung cancer, advanced stomach cancer, head and neck cancer and metastatic prostate cancer. It is administered intravenously through a vein, and is member of a family of drugs called taxanes. The drug is used to try to prevent cancer cells […]
Developed by French pharmaceutical giant, Sanofi-Aventis, Taxotere (docetaxel) was approved by the U.S. Food and Drug Administration in 1996 as a chemotherapy drug to primarily combat breast cancer.
Approved by the U.S. Food and Drug Administration primarily to combat breast cancer, Taxotere (docetaxel) has been the subject of dozens of studies over the last decade which have discovered that the Sanofi-Aventis developed drug may carry extensive health complications.
Routinely among one of the most popular breast cancer chemotherapy drugs until the expiration of its patent, Taxotere (docetaxel) was approved by the FDA in 1996 but medical professionals now claim the drug was not adequately tested.